Different Biological Pathways Between Good and Poor Inhaled Corticosteroid Responses in Asthma

Area of Science:

• Genomics
• Systems Biology
• Immunology

Background:

• Gene regulatory networks (GRNs) are crucial for understanding gene expression and cellular responses.
• Transcription factors (TFs) play a pivotal role in regulating gene expression and mediating therapeutic responses.
• Asthma treatment, particularly with inhaled corticosteroids (ICSs), can exhibit variable efficacy among patients.

Purpose of the Study:

• To construct and analyze GRNs in adult asthma patients with good (GRs) versus poor (PRs) responses to ICSs.
• To identify key TFs and their associated regulatory networks that differentiate ICS responsiveness.
• To uncover biological pathways influenced by these TFs in asthma patients.

Main Methods:

• Recruitment of 47 asthma patients classified as GRs or PRs based on ICS response.
• Genome-wide gene expression profiling of peripheral blood mononuclear cells (PBMCs).
• Construction of GRNs using Passing Attributes between Networks for Data Assimilations (PANDA).

Main Results:

• Identification of top-10 TFs with significant differences in network connectivity between GR and PR groups.
• Differential enrichment of biological pathways, including TGF-β signaling, cell cycle, and IL-4/IL-13 signaling, in GRs and PRs.
• Distinct GRN structures associated with varying responses to inhaled corticosteroids.

Conclusions:

• Multiple TFs and their associated pathways significantly influence ICS response in asthma.
• The identified TFs and pathways represent potential therapeutic targets to enhance corticosteroid sensitivity.
• Understanding GRNs offers insights into personalized medicine approaches for asthma management.